Lantheus Holdings, Inc.

NasdaqGM:LNTH Stock Report

Market Cap: US$6.2b

Lantheus Holdings Past Earnings Performance

Past criteria checks 6/6

Lantheus Holdings has been growing earnings at an average annual rate of 70.3%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 35.8% per year. Lantheus Holdings's return on equity is 36.2%, and it has net margins of 28.6%.

Key information

70.3%

Earnings growth rate

64.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate35.8%
Return on equity36.2%
Net Margin28.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem

Nov 13
Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem

Recent updates

If EPS Growth Is Important To You, Lantheus Holdings (NASDAQ:LNTH) Presents An Opportunity

Dec 21
If EPS Growth Is Important To You, Lantheus Holdings (NASDAQ:LNTH) Presents An Opportunity

Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem

Nov 13
Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem

Lantheus Holdings: Q3 Results Were Good But Market Overreacted

Nov 08

Investors Still Waiting For A Pull Back In Lantheus Holdings, Inc. (NASDAQ:LNTH)

Nov 03
Investors Still Waiting For A Pull Back In Lantheus Holdings, Inc. (NASDAQ:LNTH)

Lantheus: PYLARIFY's Enhanced Prospects Are Welcome, But Don't Get Too Greedy Now

Oct 21

Lantheus Holdings (NASDAQ:LNTH) Is Achieving High Returns On Its Capital

Oct 16
Lantheus Holdings (NASDAQ:LNTH) Is Achieving High Returns On Its Capital

We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

Sep 28
We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update)

Aug 12

Here's Why Lantheus Holdings (NASDAQ:LNTH) Has Caught The Eye Of Investors

Aug 05
Here's Why Lantheus Holdings (NASDAQ:LNTH) Has Caught The Eye Of Investors

Investors Appear Satisfied With Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Prospects As Shares Rocket 49%

Jul 17
Investors Appear Satisfied With Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Prospects As Shares Rocket 49%

Lantheus Holdings (NASDAQ:LNTH) Is Investing Its Capital With Increasing Efficiency

Jul 16
Lantheus Holdings (NASDAQ:LNTH) Is Investing Its Capital With Increasing Efficiency

Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt

Jun 24
Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt

Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus

May 23

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

May 10
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Lantheus Holdings: Powerful First Quarter

May 05

Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Apr 12
Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Lantheus Holdings: Undervalued With A Good Outlook

Feb 28

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Feb 24
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Feb 08
Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings

Jan 03
Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings

Revenue & Expenses Breakdown

How Lantheus Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:LNTH Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,497428328150
30 Jun 241,438428325140
31 Mar 241,36646129595
31 Dec 231,29632725862
30 Sep 231,206104268318
30 Jun 231,12533234316
31 Mar 231,027-18232314
31 Dec 2293528234312
30 Sep 2280110724951
30 Jun 226643223649
31 Mar 22542-3723747
31 Dec 21425-7120945
30 Sep 21390-3415444
30 Jun 21376-2714544
31 Mar 21341-810336
31 Dec 20339-139830
30 Sep 20335010025
30 Jun 203321210118
31 Mar 203522510719
31 Dec 193473210320
30 Sep 19344359820
30 Jun 19347399420
31 Mar 19347429318
31 Dec 18343419317
30 Sep 183381249416
30 Jun 183291249216
31 Mar 183331278917
31 Dec 173311239218
30 Sep 17324318418
30 Jun 17318278117
31 Mar 17307217915
31 Dec 16302277512
30 Sep 16299267512
30 Jun 16300277411
31 Mar 16295-57911
31 Dec 15293-157914
30 Sep 15299-187716
30 Jun 15301-257917
31 Mar 15303-27217
31 Dec 14302-47214
30 Sep 14296-167214
30 Jun 14291-306817
31 Mar 14286-436722
31 Dec 13284-626830

Quality Earnings: LNTH has high quality earnings.

Growing Profit Margin: LNTH's current net profit margins (28.6%) are higher than last year (8.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LNTH's earnings have grown significantly by 70.3% per year over the past 5 years.

Accelerating Growth: LNTH's earnings growth over the past year (310.8%) exceeds its 5-year average (70.3% per year).

Earnings vs Industry: LNTH earnings growth over the past year (310.8%) exceeded the Medical Equipment industry 12.9%.


Return on Equity

High ROE: LNTH's Return on Equity (36.2%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:21
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lantheus Holdings, Inc. is covered by 24 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Yuan ZhiB. Riley Securities, Inc.
Brian Kemp DolliverBrookline Capital Markets